LiSyM-Cancer II Status Seminar 2026
Abstract
Liver Systems Medicine Cancer (LiSyM-Cancer) is a multidisciplinary research network funded by the Federal Ministry of Research, Technology and Space (BMFTR) within the Framework of the National Decade Against Cancer. The funding period for LiSyM-Cancer II is July 2024 to June 2027.
The LiSyM-Cancer research network builds on the achievements of the previous network LiSyM (funding period 2016 to 2021). The main focus was extended to liver cancer in phase I (funding period 2021 to 2024) and is now directed towards clinical application in phase II.
Within the LiSyM-Cancer network, molecular and cell biologists, clinical researchers and experts in mathematical modeling are jointly conducting research to investigate the development of liver cancer from pre-existing conditions such as non-alcoholic fatty liver or liver cirrhosis. The aim of the joint project is to identify relevant biomarkers to diagnose and prevent hepatocellular carcinoma (HCC) at early stages.
Several advanced modeling frameworks, including Morpheus, are combined to study the spatio-temporal dynamics of liver tissue across all scales. We will discuss recent applications of Morpheus at this workshop.
